Form 4: Vaxcyte CFO Andrew Guggenhime Reports Stock Transaction
SEC Form 4 Filing
Andrew Guggenhime, CFO of Vaxcyte, Inc., reports disposition of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On September 3, 2024, Andrew Guggenhime, the President and CFO of Vaxcyte, Inc. (PCVX), disposed of 6,337 shares of common stock.
- The shares were surrendered to cover tax withholding obligations related to the vesting of restricted stock units.
- The transaction price was $110.15 per share.
- Following the transaction, Guggenhime directly owns 90,383 shares of Vaxcyte common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to insider stock transactions. It doesn't inherently convey positive or negative sentiment, as it simply reports a factual event.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is related to tax obligations from vested stock, which is a common occurrence.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine sale of shares to cover tax obligations.
- It provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 09/03/2024 | Date of stock transaction (disposal of shares). |
| 09/04/2024 | Date of Lock-Up Agreement mentioned in the explanation. |
| 09/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.